Oyarzún, P., Ellis, J. J., Bodén, M., & Kobe, B. (2013). PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity. BioMed Central.
Chicago-tyylinen lähdeviittausOyarzún, Patricio, Jonathan J. Ellis, Mikael Bodén, ja Boštjan Kobe. PREDIVAC: CD4+ T-cell Epitope Prediction for Vaccine Design That Covers 95% of HLA Class II DR Protein Diversity. BioMed Central, 2013.
MLA-viiteOyarzún, Patricio, Jonathan J. Ellis, Mikael Bodén, ja Boštjan Kobe. PREDIVAC: CD4+ T-cell Epitope Prediction for Vaccine Design That Covers 95% of HLA Class II DR Protein Diversity. BioMed Central, 2013.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.